Guidelines for Reporting Trial Protocols and Completed Trials Modified Due to the COVID-19 Pandemic and Other Extenuating Circumstances: The CONSERVE 2021 Statement

Aaron M. Orkin, Peter J. Gill, Davina Ghersi, Lisa Campbell, Jeremy Sugarman, Richard Emsley, Philippe Gabriel Steg, Charles Weijer, John Simes, Tanja Rombey, Hywel C. Williams, Janet Wittes, David Moher, Dawn P. Richards, Yvette Kasamon, Kenneth Getz, Sally Hopewell, Kay Dickersin, Taixiang Wu, Ana Patricia AyalaKenneth F. Schulz, Sabine Calleja, Isabelle Boutron, Joseph S. Ross, Robert M. Golub, Karim M. Khan, Cindy Mulrow, Nandi Siegfried, Joerg Heber, Naomi Lee, Pamela Reed Kearney, Rhoda K. Wanyenze, Asbjørn Hróbjartsson, Rebecca Williams, Nita Bhandari, Peter Jüni, An Wen Chan

Research output: Contribution to journal › Review article › peer-review

Fingerprint

Dive into the research topics of 'Guidelines for Reporting Trial Protocols and Completed Trials Modified Due to the COVID-19 Pandemic and Other Extenuating Circumstances: The CONSERVE 2021 Statement'. Together they form a unique fingerprint.

Medicine & Life Sciences